Sort
11,323 grants matching “glioblastoma”
Project 3: Metabolic imaging of TERT expression
$439,664Sabrina Miriam Ronen · University Of California, San Francisco · P01 · FY2023 · CA
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti
$439,642Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · P01 · FY2015 · CA
Hematopoietic Chemoprotection in Glioblastoma Patients
$439,580Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Genetic Mouse Models of Glioma
$439,544Luis F Parada · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Use of CTEP portfolio compounds to counteract phenotype conversion in GBM
$439,519Frank Pajonk · University Of California Los Angeles · R01 · FY2024 · CA
Identification of Genetic Alterations Responsible for Primary GBM Clonal Evoluti
$439,511Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$439,449Zhong-Yin Zhang · Purdue University · R01 · FY2019 · CA
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
$439,418Atique U. Ahmed · Northwestern University At Chicago · P50 · FY2021 · CA
Master Regulatory MicroRNAs in Glioblastoma
$439,227Roger Abounader · University Of Virginia · U01 · FY2019 · CA
A Predictive Prognostic Model for Glioblastoma Multiforme
$439,111Alex Bui · University Of California Los Angeles · R01 · FY2015 · CA
A Predictive Prognostic Model for Glioblastoma Multiforme
$439,111Alex Bui · University Of California Los Angeles · R01 · FY2016 · CA
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
$438,944Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2010 · CA
Targeting IDH mutations to improve seizure control in glioma patients
$438,913Craig Michael Horbinski · Northwestern University At Chicago · R01 · FY2020 · NS
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2015 · GM
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2016 · GM
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,912Linda Joy Pike · Washington University · R01 · FY2017 · GM
Mechanistic and Therapeutic Studies of GPR124/RECK/WNT7-Regulated Blood-Brain Barrier Function
$438,772Calvin J Kuo · Stanford University · R01 · FY2024 · NS
S100A4 mediated immune suppression in GBM
$438,652Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2022 · NS
S100A4 mediated immune suppression in GBM
$438,652Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2023 · NS
SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS
$438,624Linda Joy Pike · Washington University · R01 · FY2014 · GM
Crosslinking conjugates to localize and activate NK cells in glioblastoma
$438,452Benjamin W. Purow · University Of Virginia · R21 · FY2019 · NS
Mitochondria electron transport chain complexes adaptative responses to cellular stress
$438,439Corinne E. Griguer · University Of Iowa · R01 · FY2023 · NS
Circadian interventions against glioblastoma
$438,347Erik Herzog · Washington University · R01 · FY2024 · NS
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$437,810Markus Schober · New York University School Of Medicine · R01 · FY2024 · CA
A microfluidic blood-based test to monitor treatment response in glioblastoma
$437,611Shannon L Stott · Massachusetts General Hospital · R01 · FY2019 · CA